M.M. Arrebola

569 total citations
29 papers, 454 citations indexed

About

M.M. Arrebola is a scholar working on Cardiology and Cardiovascular Medicine, Organic Chemistry and Biochemistry. According to data from OpenAlex, M.M. Arrebola has authored 29 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Organic Chemistry and 7 papers in Biochemistry. Recurrent topics in M.M. Arrebola's work include Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Edible Oils Quality and Analysis (7 papers). M.M. Arrebola is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Edible Oils Quality and Analysis (7 papers). M.M. Arrebola collaborates with scholars based in Spain, Portugal and Puerto Rico. M.M. Arrebola's co-authors include J.P. De La Cruz, José Antonio González Correa, A. Guerrero, Felipe Sánchez de la Cuesta, Javier Muñoz-Marín, Juan Antonio López-Villodres, M.A. Villalobos, Alejandra Bermúdez‐Oria, África Fernández‐Prior and Martine Jodar and has published in prestigious journals such as Brain Research, Anesthesiology and British Journal of Pharmacology.

In The Last Decade

M.M. Arrebola

28 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.M. Arrebola Spain 14 105 91 87 65 62 29 454
M.A. Villalobos Spain 12 60 0.6× 62 0.7× 87 1.0× 56 0.9× 29 0.5× 16 371
C. J. A. Doelman Netherlands 11 99 0.9× 76 0.8× 149 1.7× 123 1.9× 35 0.6× 19 735
Nobuyuki Furutani Japan 7 55 0.5× 95 1.0× 76 0.9× 145 2.2× 44 0.7× 9 596
S Bezek Slovakia 12 34 0.3× 44 0.5× 63 0.7× 144 2.2× 50 0.8× 66 574
İlker Kanzık Türkiye 16 130 1.2× 51 0.6× 71 0.8× 169 2.6× 48 0.8× 46 798
Javier Muñoz-Marín Spain 11 25 0.2× 163 1.8× 85 1.0× 40 0.6× 31 0.5× 18 357
Magali Araújo United States 11 86 0.8× 33 0.4× 62 0.7× 131 2.0× 41 0.7× 21 541
Lu Gan China 14 63 0.6× 67 0.7× 43 0.5× 109 1.7× 21 0.3× 38 636
Victoriane Peugnet France 4 71 0.7× 42 0.5× 40 0.5× 149 2.3× 25 0.4× 4 449
Chander Mohan Pathak India 14 53 0.5× 30 0.3× 122 1.4× 197 3.0× 37 0.6× 22 621

Countries citing papers authored by M.M. Arrebola

Since Specialization
Citations

This map shows the geographic impact of M.M. Arrebola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.M. Arrebola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.M. Arrebola more than expected).

Fields of papers citing papers by M.M. Arrebola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.M. Arrebola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.M. Arrebola. The network helps show where M.M. Arrebola may publish in the future.

Co-authorship network of co-authors of M.M. Arrebola

This figure shows the co-authorship network connecting the top 25 collaborators of M.M. Arrebola. A scholar is included among the top collaborators of M.M. Arrebola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.M. Arrebola. M.M. Arrebola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Algarra, Manuel, Bruno B. Campos, Beatriz Alonso, et al.. (2012). Thiolated DAB dendrimer/ZnSe nanoparticles for C-reactive protein recognition in human serum. Talanta. 99. 574–579. 17 indexed citations
4.
Algarra, Manuel, et al.. (2012). CdSe and ZnSe quantum dots capped with PEA for screening C-reactive protein in human serum. Talanta. 93. 411–414. 14 indexed citations
5.
6.
Arrebola, M.M., et al.. (2010). Analytical performance of a sensitive assay for cardiac troponin I with loci™ technology. Clinical Biochemistry. 43(12). 998–1002. 22 indexed citations
7.
Correa, José Antonio González, et al.. (2008). Effects of Bemiparin, Dalteparin, and Unfractionated Heparin on Platelet Interaction With Human Subendothelium Under Flow Conditions. Journal of Pharmacological Sciences. 107(1). 103–106. 2 indexed citations
8.
Correa, José Antonio González, M.M. Arrebola, Javier Muñoz-Marín, et al.. (2007). Gender differences in the effect of aspirin on retinal ischemia, prostanoid synthesis and nitric oxide production in experimental type 1-like diabetes. Vascular Pharmacology. 47(2-3). 83–89. 6 indexed citations
9.
Correa, José Antonio González, Javier Muñoz-Marín, M.M. Arrebola, et al.. (2007). Dietary Virgin Olive Oil Reduces Oxidative Stress and Cellular Damage in Rat Brain Slices Subjected to Hypoxia–Reoxygenation. Lipids. 42(10). 921–929. 54 indexed citations
10.
Correa, José Antonio González, et al.. (2006). Antioxidant and antiplatelet effects of the alpha-tocopherol–aspirin combination in type 1-like diabetic rats. Life Sciences. 79(15). 1405–1412. 13 indexed citations
11.
Correa, José Antonio González, M.M. Arrebola, Javier Muñoz-Marín, et al.. (2006). Effects of hypoxia reoxygenation in brain slices from rats with type 1‐like diabetes mellitus. Diabetes/Metabolism Research and Reviews. 22(5). 390–400. 10 indexed citations
12.
Correa, José Antonio González, M.M. Arrebola, Javier Muñoz-Marín, et al.. (2006). Effects of aspirin plus alpha-tocopherol on brain slices damage after hypoxia-reoxygenation in rats with type 1-like diabetes mellitus. Neuroscience Letters. 400(3). 252–257. 9 indexed citations
13.
Correa, José Antonio González, M.M. Arrebola, A. Guerrero, et al.. (2004). Effects of triflusal on oxidative stress, prostaglandin production and nitric oxide pathway in a model of anoxia-reoxygenation in rat brain slices. Brain Research. 1011(2). 148–155. 12 indexed citations
14.
Guerrero, A., José Antonio González Correa, M.M. Arrebola, et al.. (2004). Antioxidant effects of a single dose of acetylsalicylic acid and salicylic acid in rat brain slices subjected to oxygen-glucose deprivation in relation with its antiplatelet effect. Neuroscience Letters. 358(3). 153–156. 28 indexed citations
15.
Cruz, J.P. De La, A. Guerrero, José Antonio González Correa, M.M. Arrebola, & Felipe Sánchez de la Cuesta. (2003). Antioxidant effect of acetylsalicylic and salicylic acid in rat brain slices subjected to hypoxia. Journal of Neuroscience Research. 75(2). 280–290. 39 indexed citations
16.
Cruz, J.P. De La, M.M. Arrebola, M.A. Villalobos, et al.. (2003). Influence of glucose concentration on the effects of aspirin, ticlopidine and clopidogrel on platelet function and platelet–subendothelium interaction. European Journal of Pharmacology. 484(1). 19–27. 20 indexed citations
17.
Arrebola, M.M., et al.. (2003). In Vitro Effects of Clopidogrel on the Platelet-Subendothelium Interaction, Platelet Thromboxane and Endothelial Prostacyclin Production, and Nitric Oxide Synthesis. Journal of Cardiovascular Pharmacology. 43(1). 74–82. 27 indexed citations
18.
Mendez, Donna, et al.. (2003). The Effect of Propofol on the Interaction of Platelets with Leukocytes and Erythrocytes in Surgical Patients. Anesthesia & Analgesia. 96(3). 713–719. 20 indexed citations
19.
Cruz, J.P. De La, M.M. Arrebola, A. Guerrero, & Felipe Sánchez de la Cuesta. (2002). Influence of nitric oxide on the in vitro antiaggregant effect of ticlopidine. Vascular Pharmacology. 38(3). 183–186. 8 indexed citations
20.
Cruz, J.P. De La, et al.. (2002). Effects of the selective inhibition of platelet thromboxane synthesis on the platelet‐subendothelium interaction. British Journal of Pharmacology. 137(7). 1082–1088. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026